Miss Devon Kuntzsch, - Medicare Physical Therapist in Ridge, NY

Miss Devon Kuntzsch, is a medicare enrolled "Physical Therapist" provider in Ridge, New York. Her current practice location is 679 Whiskey Rd, Ridge, New York. You can reach out to her office (for appointments etc.) via phone at (631) 821-8090.

Miss Devon Kuntzsch is licensed to practice in New York (license number 045265-01) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1891332102.

Contact Information

Miss Devon Kuntzsch,
679 Whiskey Rd,
Ridge, NY 11961-8352
(631) 821-8090
(631) 821-8366



Healthcare Provider's Profile

Full NameMiss Devon Kuntzsch
GenderFemale
SpecialityPhysical Therapist
Location679 Whiskey Rd, Ridge, New York
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1891332102
  • Provider Enumeration Date: 12/05/2019
  • Last Update Date: 12/05/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 8325469935
  • Enrollment ID: I20200608002167

Medical Identifiers

Medical identifiers for Miss Devon Kuntzsch such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1891332102NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist 045265-01 (New York)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Miss Devon Kuntzsch allows following entities to bill medicare on her behalf.
Provider NameLeisure Physical Therapy Pc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1083884944
PECOS PAC ID: 4082792080
Enrollment ID: O20080416000219

News Archive

Pervasis to present PVS-10200 interim data from Phase 1/2 PAD clinical study at IC3D

Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease (PAD) who undergo an angioplasty and stent procedure in the superficial femoral artery.

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics of Hørsholm, Denmark, today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the "British variant"), at the COVID-19 Testing Service Center (CTSC) of Northern Arizona University's Pathogen and Microbiome Institute (PMI), a leading U.S. infectious disease testing center.

Prostate Cancer Center of New Jersey earns ACR-ASTRO accreditation in radiation oncology

The Prostate Cancer Center of New Jersey, a partnership between AKSM/Oncology and the Urology Group of New Jersey (UGNJ), is the latest in a rapidly growing list of prostate-only treatment centers to earn the high honor of a three-year term of accreditation in radiation oncology.

Former status as elite athlete reduces risk of type 2 diabetes later in life

A study of almost 400 former elite male athletes shows that former status as an elite athlete reduces the risk of developing type 2 diabetes in later life by 28%. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes, and is by Dr Merja Laine, University of Helsinki, Helsinki, Finland, and colleagues.

Read more Medical News

› Verified 9 days ago

Provider NameHome Advantage Physical Therapy Pc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1134454119
PECOS PAC ID: 5698818110
Enrollment ID: O20100205000594

News Archive

Pervasis to present PVS-10200 interim data from Phase 1/2 PAD clinical study at IC3D

Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease (PAD) who undergo an angioplasty and stent procedure in the superficial femoral artery.

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics of Hørsholm, Denmark, today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the "British variant"), at the COVID-19 Testing Service Center (CTSC) of Northern Arizona University's Pathogen and Microbiome Institute (PMI), a leading U.S. infectious disease testing center.

Prostate Cancer Center of New Jersey earns ACR-ASTRO accreditation in radiation oncology

The Prostate Cancer Center of New Jersey, a partnership between AKSM/Oncology and the Urology Group of New Jersey (UGNJ), is the latest in a rapidly growing list of prostate-only treatment centers to earn the high honor of a three-year term of accreditation in radiation oncology.

Former status as elite athlete reduces risk of type 2 diabetes later in life

A study of almost 400 former elite male athletes shows that former status as an elite athlete reduces the risk of developing type 2 diabetes in later life by 28%. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes, and is by Dr Merja Laine, University of Helsinki, Helsinki, Finland, and colleagues.

Read more Medical News

› Verified 9 days ago

Provider NameMedcare Therapy Services:physical, Occupational & Massage Therapy,pllc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1326355132
PECOS PAC ID: 4789871773
Enrollment ID: O20101202000904

News Archive

Pervasis to present PVS-10200 interim data from Phase 1/2 PAD clinical study at IC3D

Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease (PAD) who undergo an angioplasty and stent procedure in the superficial femoral artery.

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics of Hørsholm, Denmark, today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the "British variant"), at the COVID-19 Testing Service Center (CTSC) of Northern Arizona University's Pathogen and Microbiome Institute (PMI), a leading U.S. infectious disease testing center.

Prostate Cancer Center of New Jersey earns ACR-ASTRO accreditation in radiation oncology

The Prostate Cancer Center of New Jersey, a partnership between AKSM/Oncology and the Urology Group of New Jersey (UGNJ), is the latest in a rapidly growing list of prostate-only treatment centers to earn the high honor of a three-year term of accreditation in radiation oncology.

Former status as elite athlete reduces risk of type 2 diabetes later in life

A study of almost 400 former elite male athletes shows that former status as an elite athlete reduces the risk of developing type 2 diabetes in later life by 28%. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes, and is by Dr Merja Laine, University of Helsinki, Helsinki, Finland, and colleagues.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Miss Devon Kuntzsch is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Miss Devon Kuntzsch,
679 Whiskey Rd,
Ridge, NY 11961-8352

Ph: (631) 821-8090
Miss Devon Kuntzsch,
679 Whiskey Rd,
Ridge, NY 11961-8352

Ph: (631) 821-8090

News Archive

Pervasis to present PVS-10200 interim data from Phase 1/2 PAD clinical study at IC3D

Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease (PAD) who undergo an angioplasty and stent procedure in the superficial femoral artery.

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics of Hørsholm, Denmark, today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the "British variant"), at the COVID-19 Testing Service Center (CTSC) of Northern Arizona University's Pathogen and Microbiome Institute (PMI), a leading U.S. infectious disease testing center.

Prostate Cancer Center of New Jersey earns ACR-ASTRO accreditation in radiation oncology

The Prostate Cancer Center of New Jersey, a partnership between AKSM/Oncology and the Urology Group of New Jersey (UGNJ), is the latest in a rapidly growing list of prostate-only treatment centers to earn the high honor of a three-year term of accreditation in radiation oncology.

Former status as elite athlete reduces risk of type 2 diabetes later in life

A study of almost 400 former elite male athletes shows that former status as an elite athlete reduces the risk of developing type 2 diabetes in later life by 28%. The research appears in Diabetologia, the journal of the European Association for the Study of Diabetes, and is by Dr Merja Laine, University of Helsinki, Helsinki, Finland, and colleagues.

Read more News

› Verified 9 days ago


Physical Therapist in Ridge, NY

Ms. Patricia Anne Davis, PT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 32 Scenic Hills Dr, Ridge, NY 11961
Phone: 631-345-6764    Fax: 631-345-6764
Mr. James Megna, PT
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 166 Lakeside Trl, Ridge, NY 11961
Phone: 631-300-0769    
Healthy At Home Physical Therapy, Pc
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 166 Lakeside Trl, Ridge, NY 11961
Phone: 631-300-0769    
Mr. Brendon Nolan, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 679 Whiskey Rd, Ridge, NY 11961
Phone: 631-821-8090    
Scott L Paskiewicz, PT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 679 Whiskey Rd, Leisure Physical Therapy, Ridge, NY 11961
Phone: 631-821-8090    Fax: 631-821-8366
James Barton,
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 679 Whiskey Rd, Ridge, NY 11961
Phone: 631-821-8090    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.